[Anticoagulation of the extracorporeal circuit in chronic hemodialysis]
- PMID: 9675763
[Anticoagulation of the extracorporeal circuit in chronic hemodialysis]
Abstract
Continuous or intermittent use of unfractioned heparin is the anticoagulant of choice to prevent the extracorporeal circulation clotting during the hemodialysis session. However, low molecular weight heparin (LMVH) could be an alternative treatment especially in case of high risk bleeding or during some clinical conditions such as diabetes mellitus, cerebrovascular bleeding, malignant hypertension. LMVH may be given as a single initial bolus injection generally adequate. Heparinization must be lowered or stopped when an effective anticoagulation is previously used.
Similar articles
-
The safety of heparins in end-stage renal disease.Semin Dial. 2006 Jul-Aug;19(4):305-10. doi: 10.1111/j.1525-139X.2006.00177.x. Semin Dial. 2006. PMID: 16893408 Review.
-
[Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].Anesteziol Reanimatol. 1997 Nov-Dec;(6):65-9. Anesteziol Reanimatol. 1997. PMID: 9511253 Russian. No abstract available.
-
Low-molecular-weight heparin for routine hemodialysis.Hemodial Int. 2008 Oct;12 Suppl 2:S34-7. doi: 10.1111/j.1542-4758.2008.00322.x. Hemodial Int. 2008. PMID: 18837768 Review.
-
Optimization of heparin anticoagulation for hemodialysis.Hemodial Int. 2011 Oct;15 Suppl 1:S43-8. doi: 10.1111/j.1542-4758.2011.00601.x. Hemodial Int. 2011. PMID: 22093600
-
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.Eur J Clin Pharmacol. 2018 Mar;74(3):267-274. doi: 10.1007/s00228-017-2389-x. Epub 2017 Dec 2. Eur J Clin Pharmacol. 2018. PMID: 29198062 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical